Genetic Analysis May Predict Risk Of Invasive Bladder Cancer, University of Texas MD Anderson Cancer Center Study

EurekAlert! -- DENVER – Genetic variations in the inflammation pathway may predict who would respond to Bacillus-Calmette-Guerin (BCG) treatment and who might experience a recurrence among patients with non-muscle invasive bladder cancer, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.

Back to news